Published in Perspect Sex Reprod Health on February 25, 2004
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72
The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol (2008) 2.52
Costs and effectiveness of neonatal male circumcision. Arch Pediatr Adolesc Med (2012) 2.31
A decade in review: building on the experiences of past adolescent STI/HIV interventions to optimise future prevention efforts. Sex Transm Infect (2006) 1.62
Oncogenic activities of human papillomaviruses. Virus Res (2009) 1.60
Perceptions of an ideal point-of-care test for sexually transmitted infections--a qualitative study of focus group discussions with medical providers. PLoS One (2010) 1.44
STI management and control in North America IUSTI region. Sex Transm Infect (2011) 1.38
Cost-effectiveness of human papillomavirus vaccination in the United States. Emerg Infect Dis (2008) 1.35
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35
Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proc Natl Acad Sci U S A (2008) 1.22
Sensation seeking and impulsivity: combined associations with risky sexual behavior in a large sample of young adults. J Sex Res (2012) 1.18
The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model. PLoS One (2014) 1.15
In the heart or in the head: relationship and cognitive influences on sexual risk among young couples. AIDS Behav (2012) 1.04
A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02
The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01
The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis (2010) 1.01
Applying ecological perspectives to adolescent sexual health in the United States: rhetoric or reality? Health Educ Res (2009) 0.99
Withdrawal (coitus interruptus) as a sexual risk reduction strategy: perspectives from African-American adolescents. Arch Sex Behav (2008) 0.99
Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol (2011) 0.98
Universal family-focused intervention with young adolescents: effects on health-risking sexual behaviors and STDs among young adults. Prev Sci (2014) 0.97
Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program. Milbank Q (2014) 0.95
Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening. Appl Health Econ Health Policy (2015) 0.95
Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis. Sex Transm Infect (2012) 0.95
Clinical effectiveness and cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men: risk calculators for real-world decision-making. PLoS One (2014) 0.95
Bridging the gap: using school-based health services to improve chlamydia screening among young women. Am J Public Health (2010) 0.94
Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Cost Eff Resour Alloc (2008) 0.93
Correlates of dual-method contraceptive use: an analysis of the National Survey Of Family Growth (2006-2008). Infect Dis Obstet Gynecol (2012) 0.91
Association of MDMA/ecstasy and other substance use with self-reported sexually transmitted diseases among college-aged adults: a national study. Public Health (2009) 0.90
Resources that may matter: the impact of local health department expenditures on health status. Public Health Rep (2012) 0.90
Sexually transmitted diseases among American Indians in Arizona: an important public health disparity. Public Health Rep (2010) 0.88
Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops. PLoS One (2009) 0.88
Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. Int J Drug Policy (2010) 0.87
Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women. Sex Transm Dis (2009) 0.87
Quantity, not frequency, of alcohol use moderates the association between multiple sexual partners and Trichomonas vaginalis among women attending an urban STD clinic. Sex Transm Infect (2013) 0.86
Relationships, love and sexuality: what the Filipino teens think and feel. BMC Public Health (2009) 0.86
Games Parents and Adolescents Play: Risky Behaviors, Parental Reputation, and Strategic Transfers. Econ J (London) (2008) 0.85
Cervical cancer prevention through human papillomavirus vaccination: using the "teachable moment" for educational interventions. Obstet Gynecol (2010) 0.85
Impact of a parent-child sexual communication campaign: results from a controlled efficacy trial of parents. Reprod Health (2010) 0.85
Examining racial/ethnic disparities in sexually transmitted diseases among recent heroin-using and cocaine-using women. J Womens Health (Larchmt) (2011) 0.84
Efficacy of a telephone-delivered sexually transmitted infection/human immunodeficiency virus prevention maintenance intervention for adolescents: a randomized clinical trial. JAMA Pediatr (2014) 0.84
Knowledge and Risk Perception Regarding HPV Among Latino Alternative School Students in Houston, Texas. Tipica (2009) 0.84
Barriers to health and social services for street-involved youth in a Canadian setting. J Public Health Policy (2015) 0.84
Risk Reduction Therapy for Adolescents: Targeting Substance Use and HIV/STI-Risk Behaviors. Cogn Behav Pract (2014) 0.83
Reducing the health burden of HPV infection through vaccination. Infect Dis Obstet Gynecol (2006) 0.83
Residential racial segregation and racial differences in sexual behaviours: an 11-year longitudinal study of sexual risk of adolescents transitioning to adulthood. J Epidemiol Community Health (2012) 0.82
Why does early sexual intercourse predict subsequent maladjustment? Exploring potential familial confounds. Health Psychol (2012) 0.81
Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review. Health Econ Rev (2013) 0.81
Childhood behavior problems and adolescent sexual risk behavior: familial confounding in the child and adolescent twin study in Sweden (CATSS). J Adolesc Health (2013) 0.81
HPV Prevalence in Multiple Anatomical Sites among Men Who Have Sex with Men in Peru. PLoS One (2015) 0.81
Review of Clinical Trials Testing the Effectiveness of Clinician Intervention Approaches to Prevent Sexually Transmitted Diseases in Adolescent Outpatients. Curr Pediatr Rev (2005) 0.81
Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy. Future Microbiol (2010) 0.80
Developing a dataset to track aid for reproductive, maternal, newborn and child health, 2003-2013. Sci Data (2017) 0.79
Health related quality of life in patients with anogenital warts. Health Qual Life Outcomes (2011) 0.79
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
Sexually Transmitted Infections In A Sample Of At-Risk Youth: Roles Of Mental Health And Trauma Histories. J Child Adolesc Trauma (2015) 0.79
HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia. Obstet Gynecol Int (2013) 0.78
Assessing base rates of sexual behavior using the unmatched count technique. Health Psychol Behav Med (2014) 0.78
Medical costs of STDs. Perspect Sex Reprod Health (2009) 0.78
Maternal and Paternal Psychological Control as Moderators of the Link between Peer Attitudes and Adolescents' Risky Sexual Behavior. J Early Adolesc (2014) 0.78
Expedited partner therapy for sexually transmitted diseases--are we there yet? Sex Transm Dis (2014) 0.78
Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior. Drug Alcohol Depend (2016) 0.78
It's Your Game…Keep It Real: can innovative public health prevention research thrive within a comparative effectiveness research framework? J Prim Prev (2013) 0.77
Disparities in safe sex counseling & behavior among individuals with substance dependence: a cross-sectional study. Reprod Health (2012) 0.77
Cost effectiveness of one to one STI prevention interventions. Sex Transm Infect (2007) 0.77
Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre. BMC Infect Dis (2011) 0.77
Cross-sectional study of HPV-16 infection in a population-based subsample of Hispanic adults. BMJ Open (2014) 0.76
Management strategies and cost effectiveness in the prevention of cervical cancer. Clinicoecon Outcomes Res (2009) 0.75
The wrong place at the wrong time: geographic disparities in young people's HIV Risk. J Adolesc Health (2011) 0.75
Early Onset of Sexual Intercourse and Parental Incarceration among African American Youth Living in Urban Public Housing. J Urban Health (2017) 0.75
Teaching Trainees to Deliver Adolescent Reproductive Health Services. J Pediatr Adolesc Gynecol (2015) 0.75
Sexual Health Knowledge in a Sample of Perinatally HIV-infected and Perinatally-exposed Uninfected Youth. J HIV AIDS Soc Serv (2015) 0.75
Protecting adolescents' right to seek treatment for sexually transmitted diseases without parental consent: the Arizona experience with Senate Bill 1309. Public Health Rep (2012) 0.75
Vulnerability and knowledge of sexually transmitted infections among female traders of reproductive age in enugu, Nigeria. Ann Med Health Sci Res (2014) 0.75
Inflammasomes and Their Role in Innate Immunity of Sexually Transmitted Infections. Front Immunol (2016) 0.75
Health technology assessment on cervical cancer screening, 2000-2014. Int J Technol Assess Health Care (2015) 0.75
A randomized clinical trial of tailored interventions for health promotion and recidivism reduction among homeless parolees: outcomes and cost analysis. J Exp Criminol (2015) 0.75
Patterns of empiric treatment of Chlamydia trachomatis infections in an underserved population. Fam Med (2012) 0.75
Using simulation-optimization to construct screening strategies for cervical cancer. Health Care Manag Sci (2010) 0.75
Decline in the workload associated with the serodiagnosis of syphilis in a general hospital: 1994-2004. Eur J Clin Microbiol Infect Dis (2008) 0.75
The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS (2009) 4.45
Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002. MMWR Recomm Rep (2002) 4.44
The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS (2011) 3.35
Implementing an HIV and sexually transmitted disease screening program in an emergency department. Ann Emerg Med (2006) 2.68
Heterosexual anal sex activity in the year after an STD clinic visit. Sex Transm Dis (2008) 2.59
Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstet Gynecol (2010) 2.50
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services. J Adolesc Health (2009) 1.76
Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer (2007) 1.66
Use of cervical cancer screening among insured women: the extent of missed opportunities. Health Policy (2004) 1.51
The role of bathhouses and sex clubs in HIV transmission: findings from a mathematic model. J Acquir Immune Defic Syndr (2007) 1.50
The determinants of HIV treatment costs in resource limited settings. PLoS One (2012) 1.47
Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis (2004) 1.41
Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer (2011) 1.40
On-site rapid antenatal syphilis screening with an immunochromatographic strip improves case detection and treatment in rural South African clinics. Sex Transm Dis (2007) 1.39
Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis (2003) 1.37
Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis (2006) 1.26
Peer referral for HIV case-finding among men who have sex with men. AIDS (2006) 1.25
STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis (2010) 1.23
Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.19
PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs. Health Aff (Millwood) (2012) 1.18
Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol (2008) 1.12
Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sex Transm Dis (2011) 1.12
New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior. J Acquir Immune Defic Syndr (2003) 1.11
Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa. Sex Transm Dis (2007) 1.11
Monitoring HIV testing at visits to emergency departments in the United States: very-low rate of HIV testing. J Acquir Immune Defic Syndr (2013) 1.09
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis (2012) 1.05
Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J (2009) 1.05
Uptake of regular chlamydia testing by U.S. women: a longitudinal study. Am J Prev Med (2010) 1.04
Are safety net sexually transmitted disease clinical and preventive services still needed in a changing health care system? Sex Transm Dis (2014) 1.01
Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol (2008) 1.01
A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies. Sex Transm Dis (2011) 1.01
Characteristics of HIV care and treatment in PEPFAR-supported sites. J Acquir Immune Defic Syndr (2011) 1.01
The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection. Sex Transm Dis (2013) 1.00
Suboptimal adherence to repeat testing recommendations for men and women with positive Chlamydia tests in the United States, 2008-2010. Clin Infect Dis (2012) 0.99
Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China. Sex Transm Dis (2014) 0.99
Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005. Sex Transm Dis (2009) 0.99
Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women. Sex Transm Dis (2006) 0.98
Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID): implications for surveillance. Sex Transm Dis (2003) 0.97
An outbreak of 2009 pandemic influenza A (H1N1) virus infection in an elementary school in Pennsylvania. Clin Infect Dis (2011) 0.95
Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails. J Urban Health (2004) 0.92
Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis (2010) 0.92
Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med (2006) 0.92
Chlamydia screening in a Health Plan before and after a national performance measure introduction. Obstet Gynecol (2005) 0.91
Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS (2003) 0.88
Insights into the timing of repeated testing after treatment for Chlamydia trachomatis: data and modelling study. Sex Transm Infect (2012) 0.87
Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective. J Acquir Immune Defic Syndr (2011) 0.87
Differences in access to health care services among adults in rural America by rural classification categories and age. Aust J Rural Health (2003) 0.87
A cost-effectiveness evaluation of testing and treatment of Chlamydia trachomatis infection among asymptomatic women infected with Neisseria gonorrhoeae. Sex Transm Dis (2002) 0.86
Utilization and cost of diagnostic methods for sexually transmitted infection screening among insured American youth, 2008. Sex Transm Dis (2013) 0.85
Investigating the potential public health benefit of jail-based screening and treatment programs for chlamydia. Am J Epidemiol (2013) 0.85
Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg (2006) 0.85
Provision of sexual health services to adolescent enrollees in Medicaid managed care. Am J Public Health (2002) 0.85
The economic burden of pediculosis pubis and scabies infections treated on an outpatient basis in the United States: evidence from private insurance claims data, 2001-2005. Sex Transm Dis (2009) 0.85
The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007. Sex Transm Dis (2010) 0.83
Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis. Jt Comm J Qual Improv (2002) 0.83
Receipt of HIV and STD testing services during routine general medical or gynecological examinations: variations by patient sexual risk behaviors. Sex Transm Dis (2008) 0.83
Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data. Sex Health (2013) 0.83
A community-based intervention designed to increase preventive health care seeking among adolescents: the Gonorrhea Community Action Project. Am J Public Health (2005) 0.83
State-Specific Rates of Primary and Secondary Syphilis Among Men Who Have Sex with Men - United States, 2015. MMWR Morb Mortal Wkly Rep (2017) 0.83
The Importance of Population Denominators for High-Impact Public Health for Marginalized Populations. JMIR Public Health Surveill (2016) 0.83
Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol (2011) 0.82
Mental health disorders and sexually transmitted diseases in a privately insured population. Am J Manag Care (2004) 0.81
Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care. Obstet Gynecol (2015) 0.80
Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007. Sex Transm Dis (2010) 0.80
Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005. Sex Transm Dis (2009) 0.80
The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. Sex Transm Dis (2003) 0.80
Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010. Sex Transm Dis (2013) 0.79
Anogenital warts knowledge and counseling practices of US clinicians: results from a national survey. Sex Transm Dis (2007) 0.79
Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010. MMWR Surveill Summ (2014) 0.79
Trends in receipt of sexually transmitted disease services among women 15 to 44 years old in the United States, 2002 to 2006-2010. Sex Transm Dis (2014) 0.79
Decreases in AIDS mortality and increases in primary and secondary syphilis in men who have sex with men in the United States. J Acquir Immune Defic Syndr (2008) 0.79
Demographic and Health Services Characteristics Associated With Testing for Sexually Transmitted Infections Among a Commercially Insured Population of HIV-Positive Patients. J Acquir Immune Defic Syndr (2015) 0.78
Estimating prenatal syphilis and HIV screening rates for commercially insured women. Am J Prev Med (2005) 0.78
Higher yet suboptimal chlamydia testing rates at community health centers and outpatient clinics compared with physician offices. Am J Public Health (2012) 0.78
Prenatal syphilis screening rates measured using medicaid claims and electronic medical records. Sex Transm Dis (2008) 0.78
Racial and ethnic disparities in prenatal syphilis screening among women with Medicaid-covered deliveries in Florida. Matern Child Health J (2007) 0.78
Applying a mixed-integer program to model re-screening women who test positive for C. trachomatis infection. Health Care Manag Sci (2004) 0.77
Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006. Emerg Infect Dis (2014) 0.77
Assessing the impact of state insurance policies on chlamydia screening: A panel data analysis. Health Policy (2010) 0.77
A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis (2006) 0.77
Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007. Sex Transm Dis (2011) 0.77
A refined estimate of the lifetime cost of pelvic inflammatory disease. Sex Transm Dis (2004) 0.77
Cost-effectiveness of Chlamydia vaccination programs for young women. Emerg Infect Dis (2015) 0.77
Trends in Selected Measures of Racial and Ethnic Disparities in Gonorrhea and Syphilis in the United States, 1981-2013. Sex Transm Dis (2016) 0.77
Bacterial Sexually Transmitted Disease Screening Outside the Clinic-Implications for the Modern Sexually Transmitted Disease Program. Sex Transm Dis (2016) 0.77
The economic value of reductions in gonorrhea and syphilis incidence in the United States, 1990-2003. Prev Med (2006) 0.76
Health utility measures for pelvic inflammatory disease. Sex Transm Dis (2008) 0.75
Factors that influence the cost effectiveness of gonorrhea screening in emergency departments. Sex Transm Dis (2005) 0.75